SynthesisJournal of pediatric hematology/oncology2018

Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients: A Systematic Review.

Kelly Liesse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.